Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 August 2025 | Story Lilitha Dingwayo | Photo Supplied
Mobi Readathon
Attending the MobiReadathon (left to right): Rasesemola Elias, Principal Librarian, Fezile Dabi District; Mzwandile Radebe, Principal Librarian, Thabo Mofutsanyana District Municipality; Jeannet Molopyane, Director, UFS Library and Information Services; Nomabhaso Ramugondo, Director, Free State Provincial Library Services; Elmari Kruger, Deputy Director, Motheo District Municipality; Larshan Naicker, Deputy Director, UFS Library and Information Services; Adele Bezuidenhout, Deputy Director, Fezile Dabi District Municipality; Henna Adendorff, Assistant Manager, Free State Provincial Library Services; and Thandi Gxabu, Librarian, Free State Provincial Library Services.

The University of the Free State (UFS) Department of Library and Information Services recently hosted the 2025 MobiReadathon competition, a digital reading initiative established by the City of Johannesburg Library Services. Now a national programme involving all nine provinces, the competition was introduced to Grade 8 high school learners in the Free State for the first time, with UFS playing a central role in supporting digital literacy and community empowerment.

Held at the UFS Sasol Library on 25 July 2025, the Free State leg of the 2025 MobiReadathon brought together 50 Grade 8 learners from across the province. The room buzzed with excitement as the young readers engaged in digital reading tasks and trivia challenges via mobile devices.

“I never liked reading, and because I am not fluent in English I thought I should start reading, and this initiative has been helpful for me,” said Bohlokwa Dikoetsing, a learner at Bodibeng Secondary School.

Tshepo Kgaola, also a participant, said the most exciting part of the competition was when his team won a voucher for reading after they created a story using artificial intelligence (AI).

“This initiative is part of our digital transformation agenda for public libraries,” said Nomabhaso (Rasby) Ramugondo, Director of the Free State Provincial Library Services. Ramugondo emphasised the issue of reading with understanding in South Africa, a priority that she hopes to see eradicated through programmes like the MobiReadathon. “We had asked Jeff Nyoka from the City of Johannesburg Library Services to come and do a presentation about digital literacy,” she explained. “It was then that a team of digital transformers was established to come up with initiatives like the Reja Buka Reading Festival that will help learners – and that is how the collaboration on the MobiReadathon came about in Free State.” 

“The essence of this collaboration is to promote reading development,” said Tebogo Msimango, Senior Librarian for E-learning Programmes at the City of Johannesburg. Just like Ramugondo, Msimango explains the need to promote digital reading due to the issue of learners not being able to read for meaning.

“The outcome I would like for this initiative is for learners to discover themselves and come to an understanding that with reading, one could go far,” Msimango said. “These collaborations also help with making the learners realise that they could also come into the university space, and a good example is the tour that they were taken on around the library.”

UFS Library Services played a pivotal role in facilitating the event, offering logistical support. As part of its community engagement initiatives, the university continues to collaborate on programmes that uplift local youth and promote literacy through innovation.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept